Internal Medicine, Cardiovascular Disease · Greenville, SC
NPI
1013094234
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
2 Innovation Dr, Suite 400
Greenville, SC, 29607
Phone (864) 235-7665
Groups this clinician bills Medicare through
Medicare paid, 2024
$404K
6,897 services
Medicare patients, 2024
2,008
Average age 77
Drug cost, 2024
$1.9M
10,486 prescriptions
Company payments, 2025
$57.81
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward A Stewart was code 99214 (office e&m - established), 2,578 times for 1,194 patients. In total Edward A Stewart billed 6,897 services in 55 codes, and Medicare paid $404K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-08-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,578 | 1,194 | $85.34 | $220K |
| 93000 Electrocardiogram | Office | 870 | 828 | $9.44 | $8,210 |
| 93793 Care Management/Coordination | Office | 424 | 36 | $7.61 | $3,225 |
| 85610 Clinical Chemistry | Office | 353 | 25 | $4.20 | $1,483 |
| 93306 Echocardiography (TTE/TEE) | Office | 310 | 308 | $129.14 | $40K |
| 93010 Electrocardiogram | Facility | 265 | 240 | $5.48 | $1,453 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 264 | 66 | $4.99 | $1,316 |
| 93294 External Electrocardiographic Monitoring | Office | 248 | 78 | $20.66 | $5,123 |
| 93296 External Electrocardiographic Monitoring | Office | 246 | 78 | $14.35 | $3,530 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 195 | 98 | $85.17 | $17K |
| 99213 Office E&M - Established | Office | 110 | 100 | $58.22 | $6,404 |
| 78452 Myocardial Perfusion Scan | Office | 98 | 98 | $306.47 | $30K |
| 93015 Electrocardiogram | Office | 98 | 98 | $45.91 | $4,499 |
| 99204 Office E&M - New | Office | 82 | 82 | $109.25 | $8,958 |
| Q9957 Injection, perflutren lipid microspheres, per ml | Office | 73 | 36 | $31.59 | $2,306 |
By year: 2022 $431K for 6,950 services; 2023 $428K for 6,683 services; 2024 $404K for 6,897 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 353 | 25 | $4.20 | $1,483 |
Medicare prescription drug claims, 2024
In 2024, the drug Edward A Stewart prescribed most often to Medicare patients was Eliquis (Apixaban), with 962 prescriptions and refills. In total Edward A Stewart wrote 10,486 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 962 | 1,772 | 244 | $997K |
| Metoprolol Succinate Generic | 886 | 2,429 | 271 | $14K |
| Atorvastatin Calcium Generic | 644 | 1,824 | 198 | $6,372 |
| Losartan Potassium Generic | 557 | 1,582 | 185 | $5,563 |
| Furosemide Generic | 532 | 1,266 | 193 | $2,045 |
| Amlodipine Besylate Generic | 506 | 1,263 | 164 | $2,465 |
| Spironolactone Generic | 488 | 1,352 | 162 | $4,246 |
| Carvedilol Generic | 444 | 1,075 | 121 | $3,345 |
| Metoprolol Tartrate Generic | 393 | 1,067 | 133 | $1,777 |
| Lisinopril Generic | 355 | 964 | 117 | $1,746 |
| Rosuvastatin Calcium Generic | 309 | 892 | 101 | $3,801 |
| Clopidogrel Clopidogrel Bisulfate | 287 | 809 | 99 | $2,833 |
| Repatha Sureclick Evolocumab | 249 | 448 | 58 | $252K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 240 | 692 | 83 | $3,371 |
| Nitroglycerin Generic | 228 | 280 | 155 | $2,345 |
Brand drugs: 1,896 claims; generic drugs: 8,590 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward A Stewart $57.81 ($57.81 in general payments such as food, travel and fees) from 3 companies. The largest payer was Pfizer Inc. with $21.49.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.